Herein, we conducted a retrospective study to evaluate the clinical and laboratory and radiological features of SpA patients with thrombocytosis and to explore risk factors that associated with thrombocytosis and to assess the effect of antitumor necrosis factor-α (anti-TNF-α) therapy on platelet count in SpA patients with thrombocytosis. This evidence concerns the gene TNF and thrombocytosis disease.